Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 161

Similar articles for PubMed (Select 17363091)

1.

Cardiovascular effects of Danshen.

Cheng TO.

Int J Cardiol. 2007 Sep 14;121(1):9-22. Epub 2007 Mar 23. Review.

PMID:
17363091
2.

Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use.

Zhou L, Zuo Z, Chow MS.

J Clin Pharmacol. 2005 Dec;45(12):1345-59. Review.

PMID:
16291709
3.

Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion.

Han JY, Fan JY, Horie Y, Miura S, Cui DH, Ishii H, Hibi T, Tsuneki H, Kimura I.

Pharmacol Ther. 2008 Feb;117(2):280-95. Epub 2007 Oct 16. Review.

PMID:
18048101
4.
5.

Salvia miltiorrhiza and ischemic diseases.

Ji XY, Tan BK, Zhu YZ.

Acta Pharmacol Sin. 2000 Dec;21(12):1089-94. Review.

6.

Herb-drug interactions with Danshen (Salvia miltiorrhiza): a review on the role of cytochrome P450 enzymes.

Zhou X, Chan K, Yeung JH.

Drug Metabol Drug Interact. 2012 Mar 2;27(1):9-18. doi: 10.1515/dmdi-2011-0038. Review.

PMID:
22718621
7.

Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components.

Wu WY, Wang YP.

Acta Pharmacol Sin. 2012 Sep;33(9):1119-30. doi: 10.1038/aps.2012.126. Epub 2012 Sep 3. Review.

9.

[Influence of compatibility ratio of Fufang Danshen on the dissolution of Danshen compositions].

Zeng G, Xu Q, Xiao H, Liang X.

Se Pu. 2004 Mar;22(2):141-3. Chinese.

PMID:
15712872
10.

Salvia miltiorrhiza treatment during early reperfusion reduced postischemic myocardial injury in the rat.

Nie R, Xia R, Zhong X, Xia Z.

Can J Physiol Pharmacol. 2007 Oct;85(10):1012-9.

PMID:
18066102
11.

Interaction between warfarin and danshen (Salvia miltiorrhiza).

Chan TY.

Ann Pharmacother. 2001 Apr;35(4):501-4. Review.

PMID:
11302416
12.

Danshen protects liver grafts from ischemia/reperfusion injury in experimental liver transplantation in rats.

Liang R, Bruns H, Kincius M, Lin T, Ludwig J, Dei-Anane G, Guan X, Gebhard MM, B├╝chler MW, Schemmer P.

Transpl Int. 2009 Nov;22(11):1100-9. doi: 10.1111/j.1432-2277.2009.00925.x. Epub 2009 Aug 3.

PMID:
19663939
13.

The roots of Salvia miltiorrhiza (Danshen) and Pueraria lobata (Gegen) inhibit atherogenic events: a study of the combination effects of the 2-herb formula.

Wing-Shing Cheung D, Koon CM, Ng CF, Leung PC, Fung KP, Kar-Sing Poon S, Bik-San Lau C.

J Ethnopharmacol. 2012 Oct 11;143(3):859-66. doi: 10.1016/j.jep.2012.08.011. Epub 2012 Aug 19.

PMID:
22922086
15.

The quality of randomized controlled trials on DanShen in the treatment of ischemic vascular disease.

Yu S, Zhong B, Zheng M, Xiao F, Dong Z, Zhang H.

J Altern Complement Med. 2009 May;15(5):557-65. doi: 10.1089/acm.2008.0436. Review.

PMID:
19425821
16.

[Advances in study of the pharmacological effects of danshen on hemorheology].

Chen LN, Zhu XX.

Zhongguo Zhong Yao Za Zhi. 2005 Apr;30(8):630-3, 640. Review. Chinese.

PMID:
16011293
17.

Adverse effects of herbal treatment of cardiovascular disease: what the physician must know.

Villegas JF, Barabe DN, Stein RA, Lazar E.

Heart Dis. 2001 May-Jun;3(3):169-75. Review.

PMID:
11975788
18.

[Network pharmacology study on major active compounds of Fufang Danshen formula].

Li X, Wu L, Fan X, Zhang B, Gao X, Wang Y, Cheng Y.

Zhongguo Zhong Yao Za Zhi. 2011 Nov;36(21):2911-5. Chinese.

PMID:
22308672
19.

[Protective effect of Radix Salviae multiorrhizae on myocardial ischemia reperfusion injury].

Shi G, Yin J, Chen S.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 1999 Jan;19(1):40-2. Chinese. No abstract available.

PMID:
11783260
20.

Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier.

Yu XY, Lin SG, Chen X, Zhou ZW, Liang J, Duan W, Chowbay B, Wen JY, Chan E, Cao J, Li CG, Zhou SF.

Curr Drug Metab. 2007 May;8(4):365-78.

PMID:
17504224
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk